Literature DB >> 15555912

Characterisation of steroid receptor expression in the human prostate carcinoma cell line 22RV1 and quantification of androgen effects on mRNA regulation of prostate-specific genes.

A Hartel1, A Didier, S E Ulbrich, M Wierer, H H D Meyer.   

Abstract

In this study, the effect of natural androgens on the expression of androgen-regulated genes in the human prostate carcinoma cell line 22RV1 was characterised. To clarify the usefulness of the cells for in vitro studies concerning activation of androgen responsive genes by various steroidal compounds steroid receptor expression patterns had to be characterised intensively. Expression of androgen receptor (AR), estrogen receptor alpha (ERalpha) and beta (ERbeta), progestin receptor (PR) and glucocorticoid receptor alpha and beta was investigated by the means of RT-PCR, immunocytochemistry, ligand binding or Western blot. 22RV1 cells were proved to express androgen receptor and less glucocorticoid receptor beta on mRNA level. The confirmed mutation of the androgen receptor at codon H874 slightly apart from the steroid binding pocket seemed not to cause alteration of natural steroid hormone binding. mRNA expression of all progestin and estrogen receptor isoforms as well as glucocorticoid receptor alpha could not be detected. To study functional relevance of above-mentioned findings nine androgen-regulated genes were chosen to characterise the cell line and to determine androgenic effects using highly sensitive real-time RT-PCR. Addition of the three natural steroids dihydrotestosterone (DHT), testosterone, and 19-nortestosterone significantly influenced mRNA expression profiles. All compounds under study showed clear time-dependent and androgen-specific effects on transcriptional level. The results demonstrate that the cultivated human prostate carcinoma epithelial cells have a hormonal sensitivity correlated with the presence of specific receptors and can, therefore, serve as a selective model to study hormone action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15555912     DOI: 10.1016/j.jsbmb.2004.07.004

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

1.  Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.

Authors:  Luciano De Petrocellis; Alessia Ligresti; Aniello Schiano Moriello; Mariagrazia Iappelli; Roberta Verde; Colin G Stott; Luigia Cristino; Pierangelo Orlando; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

2.  Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult.

Authors:  Janet K Hess-Wilson; Hannah K Daly; William A Zagorski; Christopher P Montville; Karen E Knudsen
Journal:  Cancer Res       Date:  2006-12-15       Impact factor: 12.701

3.  Regulation of androgen-responsive transcription by the chromatin remodeling factor CHD8.

Authors:  Tushar Menon; Joel A Yates; Daniel A Bochar
Journal:  Mol Endocrinol       Date:  2010-03-22

Review 4.  Androgen receptor signaling and mutations in prostate cancer.

Authors:  Shahriar Koochekpour
Journal:  Asian J Androl       Date:  2010-08-16       Impact factor: 3.285

5.  Circulating microRNAs as stable blood-based markers for cancer detection.

Authors:  Patrick S Mitchell; Rachael K Parkin; Evan M Kroh; Brian R Fritz; Stacia K Wyman; Era L Pogosova-Agadjanyan; Amelia Peterson; Jennifer Noteboom; Kathy C O'Briant; April Allen; Daniel W Lin; Nicole Urban; Charles W Drescher; Beatrice S Knudsen; Derek L Stirewalt; Robert Gentleman; Robert L Vessella; Peter S Nelson; Daniel B Martin; Muneesh Tewari
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-28       Impact factor: 11.205

6.  Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.

Authors:  Jan Kroon; Martin Puhr; Jeroen T Buijs; Geertje van der Horst; Daniëlle M Hemmer; Koen A Marijt; Ming S Hwang; Motasim Masood; Stefan Grimm; Gert Storm; Josbert M Metselaar; Onno C Meijer; Zoran Culig; Gabri van der Pluijm
Journal:  Endocr Relat Cancer       Date:  2015-10-19       Impact factor: 5.678

Review 7.  Curcumin against Prostate Cancer: Current Evidence.

Authors:  Deborah Termini; Danja J Den Hartogh; Alina Jaglanian; Evangelia Tsiani
Journal:  Biomolecules       Date:  2020-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.